<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04411329</url>
  </required_header>
  <id_info>
    <org_study_id>R15/2020</org_study_id>
    <nct_id>NCT04411329</nct_id>
  </id_info>
  <brief_title>Caudal Epidural With Non Opioid Adjuvants in Lumbosacral Spine Surgery</brief_title>
  <official_title>Caudal Epidural With Non Opioid Adjuvants in Lumbosacral Spine Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lumbosacral spine surgeries are accompanied with severe postoperative pain which has a
      negative effect on patients' recovery. Preemptive analgesia before lumbosacral spine
      surgeries should be implemented to prevent CNS plasticity and to provide effective pain
      relief.

      The most common way to provide pain management after spine surgery is the intravenous
      analgesia. Caudal epidural analgesia can be a highly effective method for postoperative pain
      relief.

      The most common way to provide pain management after spine surgery is the intravenous
      analgesia. Caudal epidural analgesia can be a highly effective method for postoperative pain
      relief. acting drugs last from 4-8 hours,But this can be prolonged by adding non opioid
      adjuvants like steroid( dexamethazone,betamethasone), alpha2 agonists (clonidine,
      dexmedetomidine), or their combination. This study will compare adding different non opioid
      adjuvants to bupivacaine in caudal epidural for preventive analgesia in lumbosacral spine
      surgery which can be a part of multimodal analgesia protocol.

      .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      165 patient will be enrolled in the study. They will be allocated randomly into 3 groups.
      after induction of general anesthesia and changing the patient into prone position injection
      of the study cocktail through caudal epidural route.

      In the first group patients will receive 20 ml of 0.125% bupivacaine with 8 mg dexamethasone
      before skin incision, half this volume and concentration will be injected at the end of
      surgery In the second group we will add 50µg dexmedetomidine to the previous mixture given to
      the first group, half this volume and concentration will be injected at the end of surgery In
      the third group we will add 15 IU/ml hyalurodinase to the mixture given to the second group
      half this volume and concentration will be injected at the end of surgery During the
      operation adjustment of sevoflurane concentration and fentanyl incremental doses (0.5 μg/kg)
      will be according to hemodynamic measurements.

      Clinical signs of inadequate analgesia is defined as an increase in blood pressure and heart
      rate more than 20% from baseline. Efficacy of the caudal epidural block will be tested at
      beginning of skin incision (15-20 minutes after block). If signs of inadequate analgesia are
      observed, fentanyl 0.5 µg/kg will be given and those patients will be excluded from the
      study.

      In case of decrease in Blood Pressure greater than 20% from baseline, the patient will be
      infused by 500 ml ringer lactate and if blood pressure is not responding, administration of
      increments of 3 mg ephedrine will be given. Also If heart rate decreased to 45 beats/min,
      atropine sulfate 0.01 mg/kg will be given. Muscle paralysis will be antagonized by sugmmadex
      2mg/kg at the end of surgery after switching the patient to the supine position.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 6, 2020</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The duration of analgesia</measure>
    <time_frame>postoerative 24 hours.</time_frame>
    <description>time from second dose caudal epidural block to first analgesic requirement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>VAS score from zero for (no pain) till 10 for ( the most severe intractable pain)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">165</enrollment>
  <condition>Caudal Analgesia for Lumosacral Spine Surgeries</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive 20 ml of 0.125% bupivacaine with 8 mg dexamethasone before skin incision. Haif the volume and half the concentration of this dose will be injected at the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>we will add 50µg dexmedetomidine to the previous mixture given to group A. Half the volume and half the concentration of this dose will be injected at the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group c</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>we will add 15 IU/ml hyalurodinase to the mixture given to group B. Half the volume and half the concentration of this dose will be injected at the end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>local anesthetics, steriod, alpha 2 blockers</description>
    <arm_group_label>group A</arm_group_label>
    <arm_group_label>group B</arm_group_label>
    <arm_group_label>group c</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>dexamethazone</description>
    <arm_group_label>group A</arm_group_label>
    <arm_group_label>group B</arm_group_label>
    <arm_group_label>group c</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>dexmedetomidine</description>
    <arm_group_label>group B</arm_group_label>
    <arm_group_label>group c</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyalouridinase</intervention_name>
    <description>hyalouridinase</description>
    <arm_group_label>group c</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients are aged from 18-65 years , ASA I and II, scheduled for lumbar spine surgery
             (laminectomy, discectomy, foraminotomy, fenestration or fusion) in a virgin back.

        Exclusion Criteria:

          -  Patients with multiple level fixation, revision surgery, complicated spinal canal
             stenosis, traumatic lumbar surgeries were excluded, patients with addiction, allergy
             to local anesthetics or to any drug used in the study and those with coagulation
             abnormality are also excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sanaa Farag Mahmoud</name>
      <address>
        <city>Cairo</city>
        <state>New Cairo</state>
        <zip>11835</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ainshams hospitals</name>
      <address>
        <city>Cairo</city>
        <zip>11591</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Solanki SL, Bharti N, Batra YK, Jain A, Kumar P, Nikhar SA. The analgesic effect of intrathecal dexmedetomidine or clonidine, with bupivacaine, in trauma patients undergoing lower limb surgery: a randomised, double-blind study. Anaesth Intensive Care. 2013 Jan;41(1):51-6.</citation>
    <PMID>23362890</PMID>
  </reference>
  <reference>
    <citation>Barham G, Hilton A. Caudal epidurals: the accuracy of blind needle placement and the value of a confirmatory epidurogram. Eur Spine J. 2010 Sep;19(9):1479-83. doi: 10.1007/s00586-010-1469-8. Epub 2010 May 29.</citation>
    <PMID>20512512</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 21, 2020</study_first_submitted>
  <study_first_submitted_qc>May 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2020</study_first_posted>
  <last_update_submitted>May 30, 2020</last_update_submitted>
  <last_update_submitted_qc>May 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Sanaa Farag Mahmoud Wasfy</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

